Search Results
Search for other papers by K L Gustafsson in
Google Scholar
PubMed
Search for other papers by K H Nilsson in
Google Scholar
PubMed
Search for other papers by H H Farman in
Google Scholar
PubMed
Search for other papers by A Andersson in
Google Scholar
PubMed
Search for other papers by V Lionikaite in
Google Scholar
PubMed
Search for other papers by P Henning in
Google Scholar
PubMed
Search for other papers by J Wu in
Google Scholar
PubMed
Search for other papers by S H Windahl in
Google Scholar
PubMed
Search for other papers by U Islander in
Google Scholar
PubMed
Search for other papers by S Movérare-Skrtic in
Google Scholar
PubMed
Search for other papers by K Sjögren in
Google Scholar
PubMed
Search for other papers by H Carlsten in
Google Scholar
PubMed
Search for other papers by J-Å Gustafsson in
Google Scholar
PubMed
Search for other papers by C Ohlsson in
Google Scholar
PubMed
Search for other papers by M K Lagerquist in
Google Scholar
PubMed
Introduction Estrogen, the main female reproductive hormone, is a major regulator of bone homeostasis and it is well known that estrogen deficiency after menopause increases fracture risk and that estrogen treatment decreases this risk
Search for other papers by Graham W Aberdeen in
Google Scholar
PubMed
Search for other papers by Jeffery S Babischkin in
Google Scholar
PubMed
Search for other papers by Gerald J Pepe in
Google Scholar
PubMed
Search for other papers by Eugene D Albrecht in
Google Scholar
PubMed
levels or action of estrogen are curtailed or reduced during human pregnancy, e.g. preterm birth, aromatase gene mutation, or endocrine disruptors that interfere with estrogen receptor action, lead to T2DM in offspring ( Hofman et al. 2004
Search for other papers by Shisan Xu in
Google Scholar
PubMed
Search for other papers by Fangjing Xie in
Google Scholar
PubMed
Search for other papers by Li Tian in
Google Scholar
PubMed
Search for other papers by Samane Fallah in
Google Scholar
PubMed
Search for other papers by Fatemeh Babaei in
Google Scholar
PubMed
Search for other papers by Sinai H C Manno in
Google Scholar
PubMed
Search for other papers by Francis A M Manno III in
Google Scholar
PubMed
Search for other papers by Lina Zhu in
Google Scholar
PubMed
Search for other papers by Kin Fung Wong in
Google Scholar
PubMed
Search for other papers by Yimin Liang in
Google Scholar
PubMed
Search for other papers by Rajkumar Ramalingam in
Google Scholar
PubMed
Search for other papers by Lei Sun in
Google Scholar
PubMed
Search for other papers by Xin Wang in
Google Scholar
PubMed
Search for other papers by Robert Plumb in
Google Scholar
PubMed
Search for other papers by Lee Gethings in
Google Scholar
PubMed
Search for other papers by Yun Wah Lam in
Google Scholar
PubMed
State Key Laboratory of Marine Pollution (SKLMP) at City University of Hong Kong, Hong Kong SAR, People’s Republic of China
Department of Materials Science and Engineering, College of Science and Engineering, City University of Hong Kong, Hong Kong SAR, People’s Republic of China
Search for other papers by Shuk Han Cheng in
Google Scholar
PubMed
cardiomyocytes are sexually dimorphic ( Isensee et al . 2008 , Tsuji et al . 2017 ), and estrogen receptor expression is deregulated in some cardiomyopathies ( Mahmoodzadeh et al . 2006 ). Despite the apparent involvement of estrogen in CVD, clinical
Search for other papers by Ekaterine Tskitishvili in
Google Scholar
PubMed
Search for other papers by Christel Pequeux in
Google Scholar
PubMed
Search for other papers by Carine Munaut in
Google Scholar
PubMed
Search for other papers by Renaud Viellevoye in
Google Scholar
PubMed
Search for other papers by Michelle Nisolle in
Google Scholar
PubMed
Search for other papers by Agnes Noël in
Google Scholar
PubMed
Search for other papers by Jean-Michel Foidart in
Google Scholar
PubMed
( Shankaran et al . 2005 ). So far, no medical treatment provides important neuroprotection against neonatal HIE. E4 is a natural human fetal estrogen with selective estrogen receptor modulator activity (SERM) ( Abot et al . 2014 ). Its synthesis amounts
Search for other papers by Karin L Gustafsson in
Google Scholar
PubMed
Search for other papers by Sofia Movérare-Skrtic in
Google Scholar
PubMed
Search for other papers by Helen H Farman in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Cecilia Engdahl in
Google Scholar
PubMed
Search for other papers by Petra Henning in
Google Scholar
PubMed
Search for other papers by Karin H Nilsson in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Julia M Scheffler in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Edina Sehic in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ulrika Islander in
Google Scholar
PubMed
Department of Veterans Affairs Medical Center, Long Beach, Long Beach, California, USA
Search for other papers by Ellis Levin in
Google Scholar
PubMed
Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Marie K Lagerquist in
Google Scholar
PubMed
Introduction Estrogen treatment protects against osteoporosis-related fractures, has favorable effects on several metabolic parameters, and alleviates postmenopausal symptoms. However, due to adverse effects, estrogen treatment is avoided
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Ismael González-García in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Pablo B Martínez de Morentin in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Ánxela Estévez-Salguero in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Cristina Contreras in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Amparo Romero-Picó in
Google Scholar
PubMed
KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Johan Fernø in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Rubén Nogueiras in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Carlos Diéguez in
Google Scholar
PubMed
Instituto Maimónides de Investigación Biomédica (IMIBIC)/Hospital Reina Sofía, Córdoba, Spain
FiDiPro Program, University of Turku, Turku, Finland
Search for other papers by Manuel Tena-Sempere in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Sulay Tovar in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Miguel López in
Google Scholar
PubMed
Introduction Besides the regulation of the reproductive function, estrogens have a key role in the central regulation of the energy homeostasis including both modulation of feeding behavior and energy expenditure ( Mauvais-Jarvis et al. 2013
Search for other papers by Jianshu Chen in
Google Scholar
PubMed
Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, China
Search for other papers by Jing Yu in
Google Scholar
PubMed
Search for other papers by Ruowen Yuan in
Google Scholar
PubMed
Search for other papers by Ningyin Li in
Google Scholar
PubMed
Search for other papers by Caie Li in
Google Scholar
PubMed
Search for other papers by Xiaofang Zhang in
Google Scholar
PubMed
postmenopausal hypertension patients is closely associated with the changes of sex hormone axis in postmenopausal women ( Gohar et al. 2020 , Shawky et al. 2020 ). Experimental studies have confirmed that dynamic changes in estrogen levels are significantly
Search for other papers by J N Zamarbide Losada in
Google Scholar
PubMed
Search for other papers by E Sulpice in
Google Scholar
PubMed
Search for other papers by S Combe in
Google Scholar
PubMed
Search for other papers by G S Almeida in
Google Scholar
PubMed
Search for other papers by D A Leach in
Google Scholar
PubMed
Search for other papers by J Choo in
Google Scholar
PubMed
Search for other papers by L Protopapa in
Google Scholar
PubMed
Search for other papers by M P Hamilton in
Google Scholar
PubMed
Search for other papers by S McGuire in
Google Scholar
PubMed
Search for other papers by X Gidrol in
Google Scholar
PubMed
Search for other papers by C L Bevan in
Google Scholar
PubMed
Search for other papers by C E Fletcher in
Google Scholar
PubMed
Introduction Breast cancer (BC) is the second leading cause of cancer mortality in women worldwide (1). Estrogen receptor alpha (ERα) is present in 75% of BC cases and is a dominant driver of oncogenesis in this disease subtype ( Perou et al
Search for other papers by Emma Castrique in
Google Scholar
PubMed
Search for other papers by Marta Fernandez-Fuente in
Google Scholar
PubMed
Search for other papers by Paul Le Tissier in
Google Scholar
PubMed
Search for other papers by Andy Herman in
Google Scholar
PubMed
Search for other papers by Andy Levy in
Google Scholar
PubMed
Introduction Estrogen is believed to be responsible both for increased anterior pituitary mitotic variability in estrous-cycling females compared with male rats ( Oishi et al . 1993 , McNicol & Carbajo-Perez 1999 , Nolan & Levy 2009 a ) and for
Search for other papers by Denys deCatanzaro in
Google Scholar
PubMed
Search for other papers by Tyler Pollock in
Google Scholar
PubMed
Introduction Both endogenous and exogenous estrogens exert powerful influences over mammalian female physiology and behavior. The most potent estrogen is estradiol-17β (E 2 ), which affects estrogen receptors (ER) at very low concentrations